An updated review of Parkinson's disease genetics and clinicopathological correlations

Knowledge regarding the pathophysiological basis of Parkinson's disease (PD) has been greatly expanded over the past two decades, with extraordinary contributions from the field of genetics. However, genetic classifications became complex, difficult to follow, and at times misleading, by placing well‐established monogenic forms of the disease along with others associated with risk loci, often ill characterized. The present paper summarizes the genetic, clinical, and neuropathological findings of the currently described monogenic forms of PD and also approaches the progress made in determining genetic risk factors for PD. Furthermore, the text incorporates the data into a recently proposed classification system that will hopefully bring a “user‐friendly” approach to this issue. This paper also highlights a number of inconsistencies regarding classification of PD as a single, unique clinicopathological entity—in fact, in order to achieve the development of truly innovative therapies, PD should probably be regarded clinically as a “Parkinson's disease cluster”, instead of a single disease. In the future, we hope that an in‐depth and groundbreaking understanding of PD will allow the development of truly disease‐modifying therapies that will target the molecular processes responsible for the cascade of pathological events underlying each form of PD.

[1]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[2]  W. Mandemakers,et al.  DNAJC6 Mutations Associated With Early‐Onset Parkinson's Disease , 2016, Annals of neurology.

[3]  J. Ioannidis,et al.  A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants , 2012, Journal of Medical Genetics.

[4]  J. Brunberg,et al.  Fragile X‐associated tremor/ataxia syndrome: Clinical features, genetics, and testing guidelines , 2007, Movement disorders : official journal of the Movement Disorder Society.

[5]  J. Schulz,et al.  Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. , 2005, Human molecular genetics.

[6]  M. Hallett,et al.  The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. , 2008, Archives of neurology.

[7]  A. Rajput.  Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. , 1999, Neurology.

[8]  Chuong B. Do,et al.  Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database , 2012, PLoS genetics.

[9]  R A Crowther,et al.  alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Simon C. Potter,et al.  Using genome-wide complex trait analysis to quantify ‘ missing heritability ’ in Parkinson ’ s disease , 2012 .

[11]  M. Farrer,et al.  Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[12]  A. Bonnet,et al.  EIF4G1 in familial Parkinson's disease: pathogenic mutations or rare benign variants? , 2012, Neurobiology of Aging.

[13]  J. Hardy,et al.  Study of the genetic variability in a Parkinson's Disease gene: EIF4G1 , 2012, Neuroscience Letters.

[14]  J. Nutt,et al.  Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[15]  M. Farrer,et al.  Genetic variation of Omi/HtrA2 and Parkinson's disease. , 2008, Parkinsonism & related disorders.

[16]  M. Stacy,et al.  Psychiatric disorders in rapid-onset dystonia-parkinsonism , 2012, Neurology.

[17]  K. Majamaa,et al.  Mutations in EIF4G1 are not a common cause of Parkinson's disease , 2013, European journal of neurology.

[18]  A. Lang,et al.  Fixing the broken system of genetic locus symbols , 2012, Neurology.

[19]  P. Pollak,et al.  Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers , 2012, Neurology.

[20]  Alexandra Durr,et al.  How much phenotypic variation can be attributed to parkin genotype? , 2003, Annals of neurology.

[21]  Z. Wszolek,et al.  Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes. , 2009, Parkinsonism & related disorders.

[22]  D. Hall,et al.  Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease. , 2009, Parkinsonism & related disorders.

[23]  A. Tolun,et al.  DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability. , 2013, Parkinsonism & related disorders.

[24]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[25]  G. Schellenberg,et al.  Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients , 2007, Annals of neurology.

[26]  Marc N. Offman,et al.  A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. , 2011, American journal of human genetics.

[27]  Richard Mayeux,et al.  Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors , 2011, Genetics in Medicine.

[28]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[29]  J. Massano,et al.  Clinical approach to Parkinson's disease: features, diagnosis, and principles of management. , 2012, Cold Spring Harbor perspectives in medicine.

[30]  P. Lichtner,et al.  PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson's disease. , 2009, Parkinsonism & related disorders.

[31]  Thomas Meitinger,et al.  Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.

[32]  Mohamad Saad,et al.  Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies , 2011, The Lancet.

[33]  Yusuke Nakamura,et al.  Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.

[34]  L. Ozelius,et al.  Heterogeneity of presentation and outcome in the Irish rapid‐onset dystonia–Parkinsonism kindred , 2007, Movement disorders : official journal of the Movement Disorder Society.

[35]  Michael K. Hutchinson,et al.  Translation initiator EIF4G1 mutations in familial Parkinson disease. , 2011, American journal of human genetics.

[36]  K. Marder,et al.  Association of glucocerebrosidase mutations with dementia with lewy bodies. , 2009, Archives of neurology.

[37]  Simon C. Potter,et al.  A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease , 2011, PLoS genetics.

[38]  J. Aharon-Peretz,et al.  Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. , 2004, The New England journal of medicine.

[39]  Z. Wszolek,et al.  CHCHD2 and Parkinson's disease , 2015, The Lancet Neurology.

[40]  A. Larner,et al.  Perry syndrome: A disorder to consider in the differential diagnosis of Parkinsonism , 2013, Journal of the Neurological Sciences.

[41]  M. Farrer,et al.  Glucocerebrosidase mutations in diffuse Lewy body disease. , 2011, Parkinsonism & related disorders.

[42]  Xiao-dong Ju,et al.  Two distinct clinical features and cognitive impairment in amyotrophic lateral sclerosis patients with TARDBP gene mutations in the Chinese population , 2016, Neurobiology of Aging.

[43]  Shawn K. Westaway,et al.  A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome , 2001, Nature Genetics.

[44]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[45]  J. Hardy,et al.  Syndromes of neurodegeneration with brain iron accumulation (NBIA): An update on clinical presentations, histological and genetic underpinnings, and treatment considerations , 2012, Movement disorders : official journal of the Movement Disorder Society.

[46]  A. Singleton,et al.  G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort , 2005, Movement disorders : official journal of the Movement Disorder Society.

[47]  A. Mosley,et al.  A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations , 2005, Neurology.

[48]  M. Ronaghi,et al.  Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays. , 2008, American journal of human genetics.

[49]  Nicola Pavese,et al.  Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study. , 2002, Brain : a journal of neurology.

[50]  N. Hattori,et al.  Progress in familial Parkinson's disease. , 2006, Journal of neural transmission. Supplementum.

[51]  L. Seeberger,et al.  Significant linkage of Parkinson disease to chromosome 2q36-37. , 2003, American journal of human genetics.

[52]  Christos Proukakis,et al.  A novel α-synuclein missense mutation in Parkinson disease , 2013, Neurology.

[53]  Andrew Lees,et al.  Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.

[54]  S. Tsuji,et al.  A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2–q13.1 , 2002, Annals of neurology.

[55]  M. Farrer,et al.  Parkin variants in North American Parkinson's disease: Cases and controls , 2003, Movement disorders : official journal of the Movement Disorder Society.

[56]  M. Nalls,et al.  Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. , 2009, The New England journal of medicine.

[57]  T. Kondo,et al.  Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q , 1998, Neurology.

[58]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.

[59]  H. Morris,et al.  Recent advances in Parkinson’s disease genetics , 2014, Journal of Neurology.

[60]  K. Marder,et al.  Differential effects of severe vs mild GBA mutations on Parkinson disease , 2015, Neurology.

[61]  J. Olsen,et al.  Impact of Parkinson's disease risk loci on age at onset , 2015, Movement disorders : official journal of the Movement Disorder Society.

[62]  R. Marconi,et al.  Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease , 2006, European Journal of Human Genetics.

[63]  D. Hernandez,et al.  Ethnic differences in the expression of neurodegenerative disease: Machado‐Joseph disease in Africans and Caucasians , 2002, Movement disorders : official journal of the Movement Disorder Society.

[64]  J. Lupski,et al.  Whole-Exome Sequencing in Familial Parkinson Disease. , 2016, JAMA neurology.

[65]  Va Puget.  A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations , 2006 .

[66]  Anne Corbett,et al.  Alzheimer's disease , 2011, The Lancet.

[67]  K. Doheny,et al.  Genomewide association study for susceptibility genes contributing to familial Parkinson disease , 2009, Human Genetics.

[68]  J. Erdmann,et al.  New insights into the genetics of X-linked dystonia-parkinsonism ( XDP , DYT 3 ) , 2015 .

[69]  M. Farrer,et al.  VPS35 mutations in Parkinson disease. , 2011, American journal of human genetics.

[70]  J. Jankovic,et al.  The EIF4G1 gene and Parkinson's disease , 2015, Acta neurologica Scandinavica.

[71]  A. Singleton,et al.  Lack of replication of association between GIGYF2 variants and Parkinson disease. , 2008, Human molecular genetics.

[72]  B. Levinson,et al.  Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. , 2003, The New England journal of medicine.

[73]  J. Jankovic,et al.  F-box only protein 7 gene in parkinsonian-pyramidal disease. , 2012, JAMA neurology.

[74]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[75]  R. Marconi,et al.  ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease , 2007, Neurology.

[76]  P. Pollak,et al.  LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. , 2006, The New England journal of medicine.

[77]  K. Majamaa,et al.  Parkinsonism associated with the homozygous W748S mutation in the POLG1 gene. , 2008, Parkinsonism & related disorders.

[78]  A Dürr,et al.  Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. , 2004, Lancet.

[79]  M. Rodriguez-Oroz,et al.  Parkinsonism, cognitive deficit and behavioural disturbance caused by a novel mutation in the polymerase gamma gene , 2015, Journal of the Neurological Sciences.

[80]  Patrizia Rizzu,et al.  Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.

[81]  J. Jankovic,et al.  Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families. , 2003, Human molecular genetics.

[82]  D. Birchall,et al.  T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation , 2008, Neurology.

[83]  S. Fahn.  Description of Parkinson's Disease as a Clinical Syndrome , 2003, Annals of the New York Academy of Sciences.

[84]  Vincenzo Bonifati,et al.  A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease , 2005, The Lancet.

[85]  Jan Gründemann,et al.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase , 2006, Nature Genetics.

[86]  R. Miguel,et al.  POLG1-related levodopa-responsive parkinsonism , 2014, Clinical Neurology and Neurosurgery.

[87]  E. Tolosa,et al.  Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study , 2008, The Lancet Neurology.

[88]  Chuong B. Do,et al.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease , 2014, Nature Genetics.

[89]  P. Lockhart,et al.  Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with α-synuclein pathology. , 2014, American journal of human genetics.

[90]  P. Lockhart,et al.  Profile of families with parkinsonism‐predominant spinocerebellar ataxia type 2 (SCA2) , 2004, Movement disorders : official journal of the Movement Disorder Society.

[91]  N. Hattori,et al.  Mutation Analysis of the PINK 1 Gene in 391 Patients With Parkinson Disease , 2008 .

[92]  M. Polymeropoulos,et al.  Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23 , 1996, Science.

[93]  R. Hilker,et al.  Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers , 2005, Annals of neurology.

[94]  K. Ohno,et al.  CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study , 2015, The Lancet Neurology.

[95]  A. Lang,et al.  Mutation analysis of CHCHD2 in Canadian patients with familial Parkinson's disease , 2016, Neurobiology of Aging.

[96]  R. Guerreiro,et al.  Screening for VPS35 mutations in Parkinson's disease , 2012, Neurobiology of Aging.

[97]  N. Wood,et al.  Advances in the Genetics of Parkinson's Disease: A Guide for the Clinician , 2014, Movement disorders clinical practice.

[98]  Sonja W. Scholz,et al.  Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data , 2006, The Lancet Neurology.

[99]  R. Crowther,et al.  α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .

[100]  S. Pappatà,et al.  Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability , 2010, neurogenetics.

[101]  A. Singleton,et al.  alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.

[102]  K. Kaestner,et al.  A Deleterious Mutation in DNAJC6 Encoding the Neuronal-Specific Clathrin-Uncoating Co-Chaperone Auxilin, Is Associated with Juvenile Parkinsonism , 2012, PloS one.

[103]  Elisabeth L. Moussaud-Lamodière,et al.  Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders , 2015, Neurology.

[104]  Nicholas W. Wood,et al.  Loss-of-function mutations in RAB39B are associated with typical early-onset Parkinson disease , 2015, Neurology: Genetics.

[105]  A. Messing,et al.  A new mutation in GFAP widens the spectrum of Alexander disease , 2014, European Journal of Human Genetics.

[106]  Sonja W. Scholz,et al.  Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.

[107]  N. Hattori,et al.  Mutation analysis of the PINK1 gene in 391 patients with Parkinson disease. , 2008, Archives of neurology.

[108]  D. Hernandez,et al.  Phenomenology of “Lubag” or X‐linked dystonia–parkinsonism , 2002, Movement disorders : official journal of the Movement Disorder Society.

[109]  J. Erdmann,et al.  New insights into the genetics of X-linked dystonia-parkinsonism (XDP, DYT3) , 2015, European Journal of Human Genetics.

[110]  Georg Auburger,et al.  The ubiquitin pathway in Parkinson's disease , 1998, Nature.

[111]  Nicholas Eriksson,et al.  Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease , 2011, PLoS genetics.

[112]  Marc Cruts,et al.  Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update , 2010, Human mutation.

[113]  Ronald Melki,et al.  G51D α‐synuclein mutation causes a novel Parkinsonian–pyramidal syndrome , 2013, Annals of neurology.

[114]  W. Riley,et al.  Precision Public Health for the Era of Precision Medicine. , 2016, American journal of preventive medicine.

[115]  P. Pástor,et al.  PINK1-linked parkinsonism is associated with Lewy body pathology. , 2010, Brain : a journal of neurology.

[116]  P. Ragonese,et al.  DJ‐1 mutations and parkinsonism‐dementia‐amyotrophic lateral sclerosis complex , 2005, Annals of neurology.

[117]  M. Nalls,et al.  Polygenic risk of Parkinson disease is correlated with disease age at onset , 2015, Annals of neurology.

[118]  Mariza de Andrade,et al.  High-resolution whole-genome association study of Parkinson disease. , 2005, American journal of human genetics.

[119]  A Dürr,et al.  Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[120]  M. Stacy,et al.  Cognitive impairment in rapid‐onset dystonia‐parkinsonism , 2014, Movement disorders : official journal of the Movement Disorder Society.

[121]  G. Deuschl,et al.  MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[122]  Matthew J. Farrer,et al.  Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications , 2004 .

[123]  N. Quinn,et al.  The role of pathogenic DJ‐1 mutations in Parkinson's disease , 2003, Annals of neurology.

[124]  A. Singleton,et al.  The genetics and neuropathology of Parkinson’s disease , 2012, Acta Neuropathologica.

[125]  Yuan Zhang,et al.  Mutation analysis of CHCHD2 gene in Chinese familial Parkinson's disease , 2015, Neurobiology of Aging.